Ubs Asset Management Americas Inc Pulse Biosciences, Inc. Transaction History
Ubs Asset Management Americas Inc
- $446 Billion
- Q3 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 30,476 shares of PLSE stock, worth $438,854. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,476
Previous 48,331
36.94%
Holding current value
$438,854
Previous $729,000
26.47%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PLSE
# of Institutions
87Shares Held
5.76MCall Options Held
29.4KPut Options Held
24K-
Black Rock Inc. New York, NY1.15MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.11MShares$16 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC805KShares$11.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA469KShares$6.76 Million0.0% of portfolio
-
State Street Corp Boston, MA422KShares$6.08 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $535M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...